查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1565600

人工视网膜植入的全球市场:产品·用途·终端用户·不同地区的预测 (～2032年)

Global Artificial Retina Implant Market Research Report Information by Product, by Application, and by End User and by Region - Forecast till 2032
出版日期: | 出版商: Market Research Future | 英文 77 Pages | 订单完成后即时交付

价格

全球视网膜假体植入市场规模预计将从2025年的15.1亿美元成长到2026年的19.2亿美元，预测期内复合年增长率为21.22%，到2032年将达到70亿美元。至4000 万美元。

视网膜色素变性和老年黄斑部病变 (AMD) 盛行率的上升以及提供视网膜假体植入的新创公司数量的增加是推动全球市场扩张的主要原因。

区域展望

2025年北美市占率超过50.12%。由于老年黄斑部病变 (AMD) 盛行率不断上升以及 FDA 批准的植入产品的可用性，北美视网膜假体植入市场占据了最大占有率。

预计 2025 年至 2026 年欧洲市场将大幅扩张。这主要是因为进入者经常结成策略联盟来满足顾客需求。

亚太地区视网膜假体市场预计在预测期内将以最快的速度发展。这是由于该地区老年人口不断增长，预计这将对该行业的成长做出重大贡献。根据《2022年亚太人口老化报告》，预计到2022年，亚太地区60岁及以上的人口将超过6.7亿人。到 2050 年，亚太地区的人口预计将增加两倍，达到约 13 亿。

本报告提供全球人工视网膜植入的市场调查，彙整市场定义和概要，市场成长的各种影响因素分析，市场规模的转变·预测，各种区分·各地区的明细，竞争环境，主要企业简介等资讯。

目录

第1章 摘要整理

第2章 市场概要

第3章 调查手法

第4章 市场动态

  • 促进因素
    • 老年黄斑部病变 (AMD) 和色素性视网膜炎的发生率不断增加
  • 阻碍因素
    • 与视网膜假体植入手术相关的高成本
  • 机会
    • 增加视网膜假体植入的资金和投资

第5章 市场要素分析

  • 波特的五力分析
  • 开发大脑植入物治疗视力丧失的领导公司

第6章 全球人工视网膜植入市场:各产品类型

  • 概要
  • 视网膜上植入
  • 视网膜下植入
  • 脉络薄膜上植入

第7章 全球人工视网膜植入市场:各用途

  • 概要
  • 老年性黄斑部病变 (AMD)
  • 色素性视网膜炎

第8章 全球人工视网膜植入市场:各地区

  • 概要

第9章 竞争情形

  • 竞争仪表板
  • 上市公司的股票概要
  • 比较分析:主要企业的财务趋势
  • 主要的展开·成长策略

第10章 企业简介

  • VIVANI MEDICAL INC.
  • IBIONICS
  • NANOVISION BIOSCIENCES
  • SENSOR-TECH LAB
  • LABTICIAN OPHTHALMICS, INC
  • OPTOBIONICS
  • LAMBDAVISION, INC.
  • BIONIC VISION TECHNOLOGIES
  • PIXIUM VISION
  • AXORUS
  • DATA CITATIONS
Product Code: MRFR/MED/2095-CR

Global Artificial Retina Implant Market Research Report Information by Product (Enzymes, Pharma Products, Bulk Chemicals, and Others), by Application (Bioengineering, Genomics, Vaccine Development, Drug Discovery, Fisheries, Aquaculture, Biofuels, Water Treatment Services, and Others), and by End User (Hospitals, Pharmaceutical Companies, Biotechnology Companies, and Others) and by Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast till 2032

Market Synopsis

The market for artificial retinal implants was estimated to be worth USD 1.51 billion in 2025. The Artificial Retina Implant market is expected to expand at a compound annual growth rate (CAGR) of 21.22% between 2026 and 2032, from USD 1.92 billion in 2026 to USD 7.04 billion.

The rising prevalence of retinitis pigmentosa and age-related macular degeneration (AMD), as well as the rise in the number of startups offering artificial retina implants, are the main reasons propelling the expansion of the global market.

In September 2021, Bionic Vision Technologies, a well-known brand in artificial retina technology, announced a significant collaboration with Cirtec Medical, a top medical technology business with its headquarters located in the US. The collaborative effort will facilitate the design process and allow for cooperative production of the next generation of bionic eyes. With the resources and expertise base of Cirtec Medical at its disposal, Bionic Vision Technologies hopes to advance its cutting-edge bionic eye technology and provide improved vision solutions for those with visual impairments.

Insights on Market Segments

The Artificial Retina Market is divided into three segments based on product type: suprachoroidal implants, subretinal implants, and epiretinal implants.

The artificial retina market has been divided into two segments based on application: retinitis pigmentosa and age-related macular degeneration (AMD).

Regional Perspectives

The market is divided into four regions by the study: North America, Europe, Asia-Pacific, and the Rest of the World. With a market share of more than 50.12% in 2025, the artificial retina implant market in North America held the biggest share due to the rising prevalence of age-related macular degeneration (AMD) and the availability of FDA-approved implant products. For example, Argus II is a product that the FDA has approved and is accessible in the United States.

The artificial retina implant market in Europe is expected to increase significantly between 2025 and 2026, primarily due to the frequent strategic alliances formed by industry participants to meet customer demand. For example, Pixium Vision (France) revealed in July 2022 that the first patient in the Netherlands had a successful implantation in the Prima System European pivotal trial PRIMAvera. Since then, Pixium Vision has created more clinical locations and implanted patients in the UK and Germany.

The Asia-Pacific artificial retina implant market is expected to develop at the quickest rate during the forecast period due to the region's growing geriatric population, which is expected to significantly contribute to the industry's growth. For example, the Asia-Pacific Report on Population Ageing 2022 estimates that 670 million or more persons in Asia-Pacific were 60 years of age or older in 2022. In the Asia-Pacific region, the population is predicted to treble to almost 1.3 billion by 2050.

Key Players

Bionic Vision Technologies (US), PIXIUM VISION (France), Optobionics (US), Labtician Ophthalmics, Inc. (Canada), Vivani Medical Inc. (US), iBIONICS (Canada), LambdaVision, Inc. (US), AXORUS (France), Sensor-Tech Lab (Russia), and Nanovision (US) are some of the prominent companies in the artificial retina implant market.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

  • 2.1 DEFINITION
  • 2.2 SCOPE OF THE STUDY
  • 2.3 RESEARCH OBJECTIVE AND ASSUMPTIONS
  • 2.5 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

  • 3.1 OVERVIEW
  • 3.2 DATA FLOW
    • 3.2.1 DATA MINING PROCESS
  • 3.3 PURCHASED DATABASE:
  • 3.4 SECONDARY SOURCES:
    • 3.4.1 SECONDARY RESEARCH DATA FLOW:
  • 3.5 PRIMARY RESEARCH:
    • 3.5.1 PRIMARY RESEARCH DATA FLOW:
    • 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
  • 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
    • 3.6.1 REVENUE ANALYSIS APPROACH
  • 3.7 DATA FORECASTING
    • 3.7.1 DATA FORECASTING TECHNIQUE
  • 3.8 DATA MODELING
    • 3.8.1 MICROECONOMIC FACTOR ANALYSIS:
    • 3.8.2 DATA MODELING:

4 MARKET DYNAMICS

  • 4.1 INTRODUCTION
  • 4.2 DRIVERS
    • 4.2.1 INCREASING INCIDENCES OF AGE-RELATED MACULAR DEGENERATION (AMD) AND RETINITIS PIGMENTOSA
    • 4.2.2 GROWING NUMBER OF STARTUPS ASSOCIATED WITH ARTIFICIAL RETINA IMPLANT
  • 4.3 RESTRAINTS
    • 4.3.1 HIGH COST ASSOCIATED WITH ARTIFICIAL RETINA IMPLANT PROCEDURES
  • 4.4 OPPORTUNITY
    • 4.4.1 INCREASING FUNDING & INVESTMENT FOR ARTIFICIAL RETINA IMPLANT

5 MARKET FACTOR ANALYSIS

  • 5.1 PORTER'S FIVE FORCES MODEL
    • 5.1.1 THREAT OF NEW ENTRANTS
    • 5.1.2 BARGAINING POWER OF SUPPLIERS
    • 5.1.3 THREAT OF SUBSTITUTES
    • 5.1.4 BARGAINING POWER OF BUYERS
    • 5.1.5 INTENSITY OF RIVALRY
  • 5.2 KEY PLAYERS DEVELOPING BRAIN IMPLANTS TO TREAT VISION LOSS

6 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, BY PRODUCT TYPE

  • 6.1 OVERVIEW
  • 6.2. EPIRETINAL IMPLANTS
  • 6.3. SUBRETINAL IMPLANTS
  • 6.4. SUPRACHOROIDAL IMPLANTS

7 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, BY APPLICATION

  • 7.1 OVERVIEW
  • 7.2. AGE-RELATED MACULAR DEGENERATION (AMD)
  • 7.3. RETINITIS PIGMENTOSA

8 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, BY REGION

  • 8.1 OVERVIEW

9 COMPETITIVE LANDSCAPE

  • 9.1 INTRODUCTION
  • 9.2 COMPETITOR DASHBOARD
  • 9.3 PUBLIC PLAYERS STOCK SUMMARY
  • 9.4 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
  • 9.5 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 9.5.1 PARTNERSHIP
    • 9.5.2 EXPANSION
    • 9.5.3 MERGER

10 COMPANY PROFILES

  • 10.1 VIVANI MEDICAL INC.
    • 10.1.1 COMPANY OVERVIEW
    • 10.1.2 FINANCIAL OVERVIEW
    • 10.1.3 PRODUCTS OFFERED
    • 10.1.4 KEY DEVELOPMENTS
    • 10.1.5 SWOT ANALYSIS
    • 10.1.6 KEY STRATEGIES
  • 10.2 IBIONICS
    • 10.2.1 COMPANY OVERVIEW
    • 10.2.2 FINANCIAL OVERVIEW
    • 10.2.3 PRODUCTS OFFERED
    • 10.2.4 KEY DEVELOPMENTS
    • 10.2.5 SWOT ANALYSIS
    • 10.2.6 KEY STRATEGY
  • 10.3 NANOVISION BIOSCIENCES
    • 10.3.1 COMPANY OVERVIEW
    • 10.3.2 FINANCIAL OVERVIEW
    • 10.3.3 PRODUCTS OFFERED
    • 10.3.4 KEY DEVELOPMENTS
    • 10.3.5 KEY STRATEGY
  • 10.4 SENSOR-TECH LAB
    • 10.4.1 COMPANY OVERVIEW
    • 10.4.2 FINANCIAL OVERVIEW
    • 10.4.3 PRODUCTS OFFERED
    • 10.4.4 KEY DEVELOPMENTS
    • 10.4.5 KEY STRATEGY
  • 10.5 LABTICIAN OPHTHALMICS, INC
    • 10.5.1 COMPANY OVERVIEW
    • 10.5.2 FINANCIAL OVERVIEW
    • 10.5.3 PRODUCTS OFFERED
    • 10.5.4 KEY DEVELOPMENTS
    • 10.5.5 SWOT ANALYSIS
    • 10.5.6 KEY STRATEGIES
  • 10.6 OPTOBIONICS
    • 10.6.1 COMPANY OVERVIEW
    • 10.6.2 FINANCIAL OVERVIEW
    • 10.6.3 PRODUCTS OFFERED
    • 10.6.4 KEY DEVELOPMENTS
    • 10.6.5 KEY STRATEGIES
  • 10.7 LAMBDAVISION, INC.
    • 10.7.1 COMPANY OVERVIEW
    • 10.7.2 FINANCIAL OVERVIEW
    • 10.7.3 PRODUCTS OFFERED
    • 10.7.4 KEY DEVELOPMENTS
    • 10.7.5 SWOT ANALYSIS
    • 10.7.6 KEY STRATEGIES
  • 10.8 BIONIC VISION TECHNOLOGIES
    • 10.8.1 COMPANY OVERVIEW
    • 10.8.2 FINANCIAL OVERVIEW
    • 10.8.3 PRODUCTS/SERVICES OFFERED
    • 10.8.4 KEY DEVELOPMENTS
    • 10.8.5 KEY STRATEGIES
  • 10.9 PIXIUM VISION
    • 10.9.1 COMPANY OVERVIEW
    • 10.9.2 FINANCIAL OVERVIEW
    • 10.9.3 PRODUCTS OFFERED
    • 10.9.4 KEY DEVELOPMENTS
    • 10.9.5 SWOT ANALYSIS
    • 10.9.6 KEY STRATEGIES
  • 10.10 AXORUS
    • 10.10.1 COMPANY OVERVIEW
    • 10.10.2 FINANCIAL OVERVIEW
    • 10.10.3 PRODUCTS OFFERED
    • 10.10.4 KEY DEVELOPMENTS
    • 10.10.5 KEY STRATEGIES
  • 10.11 DATA CITATIONS

LIST OF TABLES

  • TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
  • TABLE 2 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, BY PRODUCT TYPE, 2025-2032 (USD THOUSAND)
  • TABLE 3 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, BY APPLICATION, 2025-2032 (USD THOUSAND)
  • TABLE 4 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, 2025-2032 (USD THOUSAND)
  • TABLE 5 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, BY REGION, 2025-2032 (USD THOUSAND)
  • TABLE 6 PUBLIC PLAYERS STOCK SUMMARY
  • TABLE 7 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
  • TABLE 8 PARTNERSHIP
  • TABLE 9 EXPANSION
  • TABLE 10 MERGER
  • TABLE 11 VIVANI MEDICAL, INC.: PRODUCTS OFFERED
  • TABLE 12 VIVANI MEDICAL, INC.: KEY DEVELOPMENTS
  • TABLE 13 IBIONICS: PRODUCTS OFFERED
  • TABLE 14 NANOVISON: PRODUCTS OFFERED
  • TABLE 15 SENSOR-TECH LAB: PRODUCTS OFFERED
  • TABLE 16 LABTICIAN OPHTHALMICS, INC: PRODUCTS OFFERED
  • TABLE 17 OPTOBIONICS: PRODUCTS OFFERED
  • TABLE 18 LAMBDAVISION, INC.: PRODUCTS OFFERED
  • TABLE 19 BIONIC VISION TECHNOLOGIES: PRODUCTS OFFERED
  • TABLE 20 BIONIC VISION TECHNOLOGIES: KEY DEVELOPMENTS
  • TABLE 21 PIXIUM VISION: PRODUCTS OFFERED
  • TABLE 22 PIXIUM VISION: KEY DEVELOPMENTS
  • TABLE 23 AXORUS: PRODUCTS OFFERED

LIST OF FIGURES

  • FIGURE 1 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET: STRUCTURE
  • FIGURE 2 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET: MARKET GROWTH FACTOR ANALYSIS
  • FIGURE 3 PORTER'S FIVE FORCES ANALYSIS: GLOBAL ARTIFICIAL RETINA IMPLANT MARKET
  • FIGURE 4 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, PRODUCT TYPE SEGMENT ATTRACTIVENESS, 2025 & 2032 (USD THOUSAND)
  • FIGURE 5 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, BY PRODUCT TYPE, 2025 & 2032 (USD THOUSAND)
  • FIGURE 6 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET SHARE, BY PRODUCT TYPE, 2025 (% SHARE)
  • FIGURE 7 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2025 & 2032 (USD THOUSAND)
  • FIGURE 8 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, BY APPLICATION, 2025 & 2032 (USD THOUSAND)
  • FIGURE 9 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, BY REGION, 2025 & 2032 (USD THOUSAND)
  • FIGURE 10 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET SHARE, BY REGION, 2025 (% SHARE)
  • FIGURE 11 COMPETITOR DASHBOARD: ARTIFICIAL RETINA MARKET
  • FIGURE 12 VIVANI MEDICAL, INC.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 13 VIVANI MEDICAL, INC.: SWOT ANALYSIS
  • FIGURE 14 IBIONICS: SWOT ANALYSIS
  • FIGURE 15 LABTICIAN OPHTHALMICS, INC: SWOT ANALYSIS
  • FIGURE 16 LAMBDAVISION, INC.: SWOT ANALYSIS
  • FIGURE 17 PIXIUM VISION: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 18 PIXIUM VISION: SWOT ANALYSIS